T/CPHARMA 02-2020 Guidelines for Safe Use of Insulin in Healthcare Settings

Scope

Main technical content: The latest report from the International Diabetes Federation (IDF) shows that in 2019, about 463 million adults aged 20 to 79 worldwide suffered from diabetes, with an age-standardized prevalence rate as high as 8.3%. It is estimated that this rate will rise to 9.2% and 9.6% in 2030 and 2045, respectively. The latest national epidemiological survey results show that the overall prevalence of diabetes in mainland China is 12.8%, and the prevalence of prediabetes is 35.2%. Insulin is an important drug for treating diabetes, and it is widely used in China. According to the source and chemical structure, insulin can be divided into animal insulin, human insulin, and insulin analogues. According to the different characteristics of action, insulin can be divided into ultra-short-acting insulin analogues, short-acting insulin (also known as conventional insulin), medium-acting insulin, long-acting insulin, long-acting insulin analogues, premixed insulin, and premixed insulin analogues, etc. There are many types of insulin and many dosage forms, and the generic names and brand names of preparations are similar, and the packaging is similar. It is a typical kind of easily confused drugs, and it has been included in the high-alert drug catalog of many countries. Compared with other drugs, insulin is more prone to safety problems in use and more likely to cause adverse consequences. In 2017, an analysis of 11,792 medication errors (ME) reports from 657 medical institutions in 19 provinces and cities in China showed that insulin was the drug with the highest incidence of ME except sodium chloride solution. Among them, ME caused by the similar appearance, drug name, and pinyin abbreviation of insulin accounted for 18.9%, and 5 of the top 10 drugs causing ME were insulin preparations. The risk of insulin use exists in all aspects of medical behavior. Standardizing the full-process management of insulin is an important measure to ensure the safety of insuli

Development Information

Related Standards